IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement
12 août 2022 09h16 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 12, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Completes Walmart Pilot Program, Affirms Commitment to Growth
07 avr. 2022 08h47 HE
|
IMAC Holdings, Inc.
The Company plans to add 20 locations in the next 12 months BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the...
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
16 févr. 2022 09h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
IMAC Holdings Expands into Louisiana with Baton Rouge Orthopedic Business
04 oct. 2021 09h30 HE
|
IMAC Holdings, Inc.
Allen Johnston, M.D. Joins IMAC as a Medical Director, Expanding Company’s Footprint, Expertise in Sports Medicine BRENTWOOD, Tenn, Oct. 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings,...
IMAC Holdings, Inc. Announces Initiation of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
13 juil. 2021 09h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, July 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the second cohort of its Phase 1 clinical trial for...
IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer
07 janv. 2021 08h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease
30 déc. 2020 09h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Dec. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
30 nov. 2020 16h05 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 30, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. To Participate in the Virtual Fall Investor Summit on November 16-18, 2020
13 nov. 2020 08h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 13, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...